CSIMarket
 


Conformis inc   (CFMS)
Other Ticker:  
 

Conformis Inc 's Leverage Ratio

CFMS's quarterly Leverage Ratio and Total Liabilities, Equity growth


In Spite of the repayements of liabilities of -4.32%, in II Quarter 2023 ,Leverage Ratio deteriorated to 1.06, below the Conformis Inc 's average Leverage Ratio.

Within Medical Equipment & Supplies industry in the second quarter 2023, 134 other companies have achieved lower Leverage Ratio than Conformis Inc in the II Quarter 2023. While Leverage Ratio total ranking has deteriorated compared to the first quarter 2023 from 740 to 1969 .

Explain Leverage Ratio?
Who are CFMS Customers?
What are CFMS´s Total Liabilities?


CFMS Leverage Ratio (Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
Y / Y Equity Change -56.39 % -48.11 % -46.12 % -46.67 % -41.6 %
Y / Y Total Liabilities Change -19.41 % -13.59 % -11.69 % 1.16 % 1.75 %
Leverage Ratio MRQ 1.06 0.79 0.7 0.68 0.57
CFMS's Total Ranking # 1969 # 740 # 662 # 1416 # 1225
Seq. Equity Change -28.24 % -17.63 % -11.42 % -16.7 % -14.61 %
Seq. Total Liabilities Change -4.32 % -6.83 % -8.61 % -1.09 % 2.6 %



Leverage Ratio second quarter 2023 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 135
Healthcare Sector # 649
Overall Market # 1969


Leverage Ratio Statistics
High Average Low
7.01 1.34 0.12
(Jun 30 2020)   (Sep 30 2015)




Financial Statements
Conformis Inc 's Equity $ 32 Millions Visit CFMS's Balance sheet
Conformis Inc 's Total Liabilities $ 34 Millions Visit CFMS's Balance sheet
Source of CFMS's Sales Visit CFMS's Sales by Geography


Cumulative Conformis Inc 's Leverage Ratio

CFMS's Leverage Ratio for the trailling 12 Months

CFMS Leverage Ratio

(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
Y / Y Equity TTM Growth -56.39 % -48.11 % -46.12 % -46.67 % -41.6 %
Y / Y Total Liabilities TTM Growth -19.41 % -13.59 % -11.69 % 1.16 % 1.75 %
Leverage Ratio TTM 0.77 0.67 0.59 0.52 0.45
Total Ranking TTM # 1566 # 1451 # 1537 # 1358 # 1223
Seq. Equity TTM Growth -28.24 % -17.63 % -11.42 % -16.7 % -14.61 %
Seq. Total Liabilities TTM Growth -4.32 % -6.83 % -8.61 % -1.09 % 2.6 %


On the trailing twelve months basis Despite of the repayements of liabilities of -4.32% in the trailing twelve months ending in II Quarter 2023, Leverage Ratio improved to 0.77, below Conformis Inc 's average Leverage Ratio.
Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Medical Equipment & Supplies industry CFMS recorded the lowest Leverage Ratio. While Leverage Ratio total ranking has deteriorated during the twelve months ending in the II Quarter 2023, compared to the prior period, from 3 to 93.

Explain Leverage Ratio?
Who are CFMS Customers?
What are CFMS´s Total Liabilities?

TTM Leverage Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 0
Healthcare Sector # 1
Within the Market # 1969


trailing twelve months Leverage Ratio Statistics
High Average Low
4.87 1.43 0.41
(Dec 31 2020)   (Mar 31 2022)




Companies with similar Leverage Ratio in the quarter ending Jun 30 2023, within Medical Equipment & Supplies Industry Leverage RatioJun 30 2023 MRQ Total LiabilitiesJun 30 2023 MRQ Equity
The Pennant Group Inc   2.89 $ 386.633  Millions$ 133.698  Millions
Bioventus Inc   2.80 $ 653.767  Millions$ 233.341  Millions
Uphealth Inc   2.47 $ 210.941  Millions$ 85.415  Millions
Strata Skin Sciences Inc   2.26 $ 38.295  Millions$ 16.909  Millions
Dexcom Inc   2.19 $ 4,602.600  Millions$ 2,100.400  Millions
Nuo Therapeutics Inc   1.94 $ 0.914  Millions$ 0.471  Millions
Conmed Corporation  1.89 $ 1,476.447  Millions$ 780.194  Millions
Minerva Surgical Inc   1.83 $ 48.556  Millions$ 26.587  Millions
Vaso Corporation  1.82 $ 45.813  Millions$ 25.233  Millions
Intelligent Bio Solutions Inc   1.78 $ 6.556  Millions$ 3.687  Millions
Lucid Diagnostics Inc   1.77 $ 26.683  Millions$ 15.071  Millions
Artivion Inc   1.75 $ 495.353  Millions$ 282.508  Millions
Tandem Diabetes Care Inc   1.75 $ 576.284  Millions$ 329.234  Millions
Iridex Corp  1.75 $ 23.489  Millions$ 13.450  Millions
Msa Safety Incorporated  1.65 $ 1,368.020  Millions$ 831.131  Millions
Novocure Limited  1.63 $ 675.781  Millions$ 415.683  Millions
Patterson Companies Inc   1.53 $ 1,700.880  Millions$ 1,111.241  Millions
Zynex inc   1.45 $ 90.302  Millions$ 62.267  Millions
Tela Bio Inc   1.36 $ 54.381  Millions$ 40.005  Millions
Helius Medical Technologies inc   1.35 $ 6.181  Millions$ 4.572  Millions
Therapeutic Solutions International Inc   1.34 $ 1.995  Millions$ 1.491  Millions
Masimo Corp  1.30 $ 1,702.900  Millions$ 1,308.300  Millions
Acutus Medical Inc   1.29 $ 56.554  Millions$ 43.741  Millions
Stereotaxis Inc   1.26 $ 26.929  Millions$ 21.386  Millions
Cadre Holdings Inc   1.22 $ 219.417  Millions$ 180.502  Millions
Soleno Therapeutics Inc  1.19 $ 14.840  Millions$ 12.426  Millions
Lensar Inc   1.18 $ 38.506  Millions$ 32.690  Millions
Cytosorbents Corporation  1.18 $ 28.350  Millions$ 24.095  Millions
Stryker Corp  1.15 $ 20,048.000  Millions$ 17,361.000  Millions
Nuvasive Inc  1.15 $ 1,028.117  Millions$ 892.543  Millions

Date modified: 2023-08-03T08:30:13+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com